Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Regulation of Pathological Blood Brain Barrier for Intracranial Enhanced Drug Delivery and Anti-glioblastoma Therapeutics

Version 1 : Received: 12 July 2022 / Approved: 14 July 2022 / Online: 14 July 2022 (15:02:52 CEST)

How to cite: Wang, K.; Zhang, F.; Wen, C.; Huang, Z.; Zhang, Y.; Hu, Z.; Hu, F.; Wen, L. Regulation of Pathological Blood Brain Barrier for Intracranial Enhanced Drug Delivery and Anti-glioblastoma Therapeutics. Preprints 2022, 2022070225. https://doi.org/10.20944/preprints202207.0225.v1 Wang, K.; Zhang, F.; Wen, C.; Huang, Z.; Zhang, Y.; Hu, Z.; Hu, F.; Wen, L. Regulation of Pathological Blood Brain Barrier for Intracranial Enhanced Drug Delivery and Anti-glioblastoma Therapeutics. Preprints 2022, 2022070225. https://doi.org/10.20944/preprints202207.0225.v1

Abstract

The blood brain barrier (BBB) is an essential component in regulating and maintaining the homeostatic microenvironment of the central nervous system (CNS). During the occurrence and development of glioblastoma (GBM), BBB is pathologically disrupted with markedly increased permeability. Due to the obstruction imposed by the BBB, strategies currently employed for GBM therapeutics still obtain a very low success rate and lead to systemic toxicity. Moreover, chemotherapy could promote pathological BBB functional restoration, accompanied with a prominent decrease of intracerebral therapeutics transportion during GBM multiple administration, resulting in chemotherapy failure for GBM treatment. The effective delivery of therapeutics into the brain still faces with severe challenges. Regulation of pathological BBB for enhanced transporting of therapeutics across the barrier may provide new opportunities for effective and safe treatment of GBM. This article reviews the structure and function of BBB in physiological state, the mechanisms underlying BBB pathological fenestration during the development of GBM, and the therapeutic strategies of GBM based on BBB intervention and therapeutic drugs transporting across the BBB.

Keywords

blood brain barrier; physiological; pathological; glioblastoma; intervention

Subject

Medicine and Pharmacology, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.